Evidence map›Paper›PMID 21939239›Full record

ReviewChemical reviews2011

Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.

Victoria A Blaho, Timothy Hla

Abstract readReview
In one paragraph

Review in Chemical reviews, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 95 papers.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

95 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Role of Sphingosine-1-Phosphate Signaling Pathway in Pancreatic Diseases.International journal of molecular sciences · 2024
    Review
  6. Review
  7. Tissue Engineered 3D Constructs for Volumetric Muscle Loss.Annals of biomedical engineering · 2024
    Review
  8. Review
  9. Review
  10. Article
  11. CLIC4 Regulates Endothelial Barrier Control by Mediating PAR1 Signaling via RhoA.Arteriosclerosis, thrombosis, and vascular biology · 2023
    Article
  12. Review
  13. Article
  14. Visualizing Sphingosine-1-Phosphate Receptor 1(S1PCellular and molecular neurobiology · 2023
    Article
  15. Signal Transduction and Gene Regulation in the Endothelium.Cold Spring Harbor perspectives in medicine · 2023
    Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Victoria A BlahoCenter for Vascular Biology, Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, New York 10065, USA.
Timothy Hla

Funding

Vascular Pathophysiology and History Core (VPHC)P01HL070694 · NHLBI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI HLA, TIMOTHY TUN · 2002 to 2013
$17.5M
Sphingolipid modulators of vascular growth & homeostasisR37HL067330 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI HLA, TIMOTHY TUN · 2006 to 2015
$3.9M
Sphingosine 1-phosphate receptors in vascular homeostasis and pathologyR01HL089934 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI HLA, TIMOTHY TUN · 2008 to 2016
$3.3M
Modulation of tumor-associated macrophage phenotype by S1P receptorsF32CA142117 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI BLAHO, VICTORIA ALISON · 2009 to 2011
$157k
NCI NIH HHS F32 CA142117NCI NIH HHS F32CA142117NHLBI NIH HHS HL70694NHLBI NIH HHS HL89934NHLBI NIH HHS P01 HL070694NHLBI NIH HHS R01 HL089934NHLBI NIH HHS R37 HL067330
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsLysophospholipidsMolecular ChaperonesReceptors, Lysophosphatidic AcidSphingosineLysophospholipidsMolecular ChaperonesReceptors, Lysophosphatidic AcidSphingosinesphingosine 1-phosphate

Identifiers

PMID21939239
PMCPMC3216694

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.